Various alphabetized medical records
Industries

Life Sciences Intellectual Property

CRA has assisted clients in intellectual property (IP) matters concerning products and services in the life sciences sector, including Hatch-Waxman and BPCIA matters. We have also addressed patent, trademark, and copyright infringement, trade secret misappropriation, and IP licensing. Our experts have quantified damages based on lost profit and reasonable royalty methods and provided opinions on irreparable harm. In addition, we have experience addressing other forms of relief, such as rescission and disgorgement.

Our understanding of the unique dynamics of different therapeutic areas informs assessments of commercial success as a secondary indicator of non-obviousness and the claimed nexus between patented technologies and product success.

Engagements

  • 01
    Breach of contract damages analysis and testimony
    CRA developed economic analyses to determine damages in a breach of contract case related to microarray technology. CRA prepared a preliminary damages report...
    View engagement
  • 02
    CRA assess commercial success for rare disease drug
    CRA addressed issues relating to commercial success in patent litigation on behalf of an innovator company commercializing a drug for a rare disease. CRA...
    View engagement
  • 03
    CRA assesses damages for theft of trade secrets
    CRA provided expert reports and trial testimony in trade secret litigation concerning an early-stage oncology product candidate. Plaintiff claimed that the...
    View engagement

Subscribe to receive our latest Insights.

Subscribe